Lipid Modification Guidelines
Author: Ebun Ojo, Lead Pharmacist for Hypertension, ACS and Lipid Modification, SY ICB
Hilde Storkes, Formulary Pharmacist, SY ICB
Dr Paul Masters, Consultant Chemical Pathologist, Sheffield Teaching Hospital
Dr Hannah Delaney, Consultant Chemical Pathologist, Sheffield Teaching Hospital
Date Published: January 2022 (author updated January 2024)
Date to Review: July 2026
Guidance on management of lipids in primary prevention and secondary prevention, including patients with diabetes and CKD.
Lipid optimisation for the primary prevention of cardiovascular disease in adults - https://www.intranet.sheffieldccg.nhs.uk/Downloads/Medicines%20Management/prescribing%20guidelines/Lipid_modification_primary_prevention.pdf
Lipid optimisation for the secondary prevention of cardiovascular disease in adults - https://www.intranet.sheffieldccg.nhs.uk/Downloads/Medicines%20Management/prescribing%20guidelines/Lipid_modification_secondary_prevention.pdf
Managing raised triglycerides - https://www.intranet.sheffieldccg.nhs.uk/Downloads/Medicines%20Management/prescribing%20guidelines/Raised_triglycerides_flowchart.pdf